Imatinib and thrombocytopenia Patient Reports February 11, 2012

Imatinib Side Effects Report #4707004-X
Imatinib side effect was reported by a Health Professional from UNITED STATES on July 05, 2005. Female patient, 63 years of age, weighting 122.6 lb, was diagnosed with glioblastoma multiforme and was treated with Imatinib. After drug was administered, patient experienced the following side effects: anaemia, thrombocytopenia. Imatinib dosage: 400 MG, PO QD. During the same period patient was treated with HYDROXYUREA, ACTONEL, DIOVAN, NORVASC, HYDROXYCHLOROQUINE SULPHATE, LEVOXYL. Patient recovered.

Imatinib Side Effects Report #4544461-6
Imatinib side effect was reported by a Health Professional from on Jan 03, 2005. Male patient, 49 years of age, weighting 223.5 lb, was diagnosed with glioblastoma multiforme and was treated with Imatinib. After drug was administered, patient experienced the following side effects: neutrophil count decreased, thrombocytopenia. Imatinib dosage: 600MG PO QD X 8 DAYS. During the same period patient was treated with TEMOZOLOMIDE, DECADRON, PROTONIX, TEGRETOL, SINGULAIR, ALLEGRA. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #4821031-3
Imatinib side effect was reported by a Health Professional from UNITED STATES on Nov 04, 2005. Female patient, weighting 129.2 lb, was diagnosed with glioblastoma multiforme and was treated with Imatinib. After drug was administered, patient experienced the following side effects: neoplasm progression, platelet count increased, thrombocytopenia. Imatinib dosage: 400 MG PO BID X 8 DAYS. During the same period patient was treated with TEMOZOLOMIDE SCHERING PLOUGH, LOVENOX SC, PROTONIX, ZOLOFT, METFORMIN, COLACE. Patient recovered.

Imatinib Side Effects Report #4582904-2
Imatinib side effect was reported by a Physician from on Feb 04, 2005. Female patient, 76 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: bone marrow depression, chromosome analysis abnormal, neutropenia, pancytopenia, thrombocytopenia, trisomy 8. Imatinib dosage: 600 MG TO 200 MG/DAY. Patient recovered.


Imatinib Side Effects Report #4582920-0
Imatinib side effect was reported by a Physician from on Feb 04, 2005. Male patient, 71 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: bone marrow depression, chromosome analysis abnormal, neutropenia, pancytopenia, thrombocytopenia. Imatinib dosage: 600 MG/DAY. Patient recovered.

Imatinib Side Effects Report #4582905-4
Imatinib side effect was reported by a Physician from on Feb 04, 2005. Female patient, 66 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: bone marrow depression, chromosome analysis abnormal, neutropenia, pancytopenia, thrombocytopenia, trisomy 8. Imatinib dosage: 400 MG/DAY. Patient recovered.

Imatinib Side Effects Report #5128465-0
Imatinib side effect was reported by a Physician from UNITED STATES on Oct 09, 2006. Male patient, 55 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: blast cell proliferation, myelodysplastic syndrome, thrombocytopenia. Imatinib dosage: 800 MG/D. Patient died on 01/01/2006.

Imatinib Side Effects Report #5718064-1
Imatinib side effect was reported by a Health Professional from FRANCE on Apr 11, 2008. Male patient, 54 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: anaemia, bone pain, chloroma, thrombocytopenia. Imatinib dosage: unknown. Patient recovered.

Imatinib Side Effects Report #4582912-1
Imatinib side effect was reported by a Physician from on Feb 04, 2005. Female patient, 53 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: bone marrow depression, chromosome analysis abnormal, neutropenia, pancytopenia, thrombocytopenia, trisomy 8. Imatinib dosage: 400 MG/DAY. Patient recovered.


Imatinib Side Effects Report #4582919-4
Imatinib side effect was reported by a Physician from on Feb 04, 2005. Female patient, 43 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: bone marrow depression, chromosome analysis abnormal, neutropenia, pancytopenia, thrombocytopenia, trisomy 8. Imatinib dosage: 400 MG/DAY. Patient recovered.

Imatinib Side Effects Report #4889692-0
Imatinib side effect was reported by a Consumer or non-health professional from KOREA, REPUBLIC OF on Jan 13, 2006. Male patient, 21 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: hip arthroplasty, post procedural haemorrhage, thrombocytopenia. Imatinib dosage: unknown. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #5231301-5
Imatinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 05, 2007. Female patient, 47 years of age, was treated with Imatinib. After drug was administered, patient experienced the following side effects: hepatic enzyme abnormal, thrombocytopenia. Imatinib dosage: unknown. During the same period patient was treated with MERCAPTOPURINE. Patient recovered.

Imatinib Side Effects Report #5999916-4
Imatinib side effect was reported by a Health Professional from SPAIN on Dec 04, 2008. Female patient, 46 years of age, was treated with Imatinib. After drug was administered, patient experienced the following side effects: anaemia, electrocardiogram qrs complex abnormal, intracardiac mass, intracardiac thrombus, left ventricular dysfunction, pancreatic enzymes increased, surgery , thrombocytopenia. Imatinib dosage: 200 MG/DAY. During the same period patient was treated with METHYLPREDNISOLONE. Patient was hospitalized. Patient recovered.